Literature DB >> 26811947

Ultrasound-guided pulsed radiofrequency treatment of the pudendal nerve in chronic pelvic pain.

D Ozkan1, T Akkaya2, S Yildiz3, A Comert4.   

Abstract

Chronic pelvic pain is a condition that can be caused by pudendal neuralgia, interstitial cystitis, piriformis syndrome and neuropathy of the ilioinguinal, iliohypogastric and genitofemoral nerves. Based on three case reports this article discusses the clinical effectiveness of pulsed high-frequency radiofrequency (PRF) treatment applied to the pudendal nerve under ultrasound guidance in medicinally treated patients with chronic pelvic pain.

Entities:  

Keywords:  Analgesia; Case study; Cystitis, interstitial; Neuralgia; Ultrasonography, interventional

Mesh：

Year:  2016        PMID： 26811947     DOI： 10.1007/s00101-015-0133-4

Source DB:  PubMed          Journal:  Anaesthesist        ISSN： 0003-2417            Impact factor:   1.041


  8 in total

1.  Randomized controlled trial comparing pudendal nerve block under ultrasound and fluoroscopic guidance.

Authors:  Geoff A Bellingham; Anuj Bhatia; Chin-Wern Chan; Philip W Peng
Journal:  Reg Anesth Pain Med       Date:  2012 May-Jun       Impact factor: 6.288

2.  Analgesic effect of bilateral ultrasound-guided pudendal nerve blocks in management of interstitial cystitis.

Authors:  Lyn Li Lean; Dominic Hegarty; Dominic Harmon
Journal:  J Anesth       Date:  2012-02       Impact factor: 2.078

Review 3.  Ultrasound-guided interventional procedures for patients with chronic pelvic pain - a description of techniques and review of literature.

Authors:  Philip W H Peng; Paul S Tumber
Journal:  Pain Physician       Date:  2008 Mar-Apr       Impact factor: 4.965

4.  Ultrasound-guided pulsed radiofrequency treatment of the intercostal nerve: three cases.

Authors:  Taylan Akkaya; Derya Ozkan
Journal:  J Anesth       Date:  2013-06-04       Impact factor: 2.078

5.  Pudendal block in transurethral prostatectomy: A randomised trial.

Authors:  Taylan Akkaya; Derya Ozkan; Nihat Karakoyunlu; Julide Ergil; Haluk Gumus; Hamit Ersoy; Ayhan Comert; Halil I Acar; Selda Yildiz
Journal:  Eur J Anaesthesiol       Date:  2015-09       Impact factor: 4.330

6.  Clinical comparision of intravesical hyaluronic acid and hyaluronic acid-chondroitin sulphate therapy for patients with bladder pain syndrome/interstitital cystitis.

Authors:  Omer Gülpınar; Aytaç Kayış; Evren Süer; Mehmet İlker Gökçe; Adil Güçal Güçlü; Nihat Arıkan
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

Review 7.  Treatment of interstitial cystitis.

Authors:  Michael B Chancellor; Naoki Yoshimura
Journal:  Urology       Date:  2004-03       Impact factor: 2.649

8.  Successful treatment of refractory pudendal neuralgia with pulsed radiofrequency.

Authors:  Ellen E Rhame; Kenneth A Levey; Christopher G Gharibo
Journal:  Pain Physician       Date:  2009 May-Jun       Impact factor: 4.965
  8 in total
  4 in total

Review 1.  [Interdisciplinary position paper: the value of radiofrequency denervation in the treatment of chronic pain].

Authors:  Rudolf Likar; Johann Auer; Albert Chavanne; Wilfried Ilias; Michael Kern; Petra Krepler; Hans-Georg Kress; Ulrike Lischnig; Gernot Maurer; Oliver Sommer; Martin C Spendel; Siegfried Thurnher; Karl Wohak; Andreas Wolf; Michael Wölkhart
Journal:  Schmerz       Date:  2021-01-14       Impact factor: 1.107

2.  Interventional treatment options for women with pelvic pain.

Authors:  Joseph E Torres; Ameet S Nagpal; Alice Iya; Donald McGeary; Malathy Srinivasan
Journal:  Curr Phys Med Rehabil Rep       Date:  2020-05-14

3.  Clinical effect and safety of pulsed radiofrequency treatment for pudendal neuralgia: a prospective, randomized controlled clinical trial.

Authors:  Hongwei Fang; Jinyuan Zhang; Yu Yang; Le Ye; Xiangrui Wang
Journal:  J Pain Res       Date:  2018-10-16       Impact factor: 3.133

4.  Impact of ultrasound diagnosis for chronic pelvic pain.

Authors:  Xiao-Hui Wang; Jing-Jun Xu; Guang Yang; Tian-You Xin
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.